Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (6): 1709-1716.doi: 10.13481/j.1671-587X.20250628
• Methodology • Previous Articles Next Articles
Qiuyuan SU1,Ling ZHAO1,Jiajia TAN1,Shien MO1,Haiqin ZHOU1,Fangfang LU1,Yi WEI1,Yang ZHOU1,Yan KUANG1,2(
)
Received:2025-01-12
Accepted:2025-02-22
Online:2025-11-28
Published:2025-12-15
Contact:
Yan KUANG
E-mail:kuangyan_2004@163.com
CLC Number:
Qiuyuan SU,Ling ZHAO,Jiajia TAN,Shien MO,Haiqin ZHOU,Fangfang LU,Yi WEI,Yang ZHOU,Yan KUANG. Construction of SPHK1 overexpression lentiviral vectors and establishment of stable transfected SKOV3 cell lines[J].Journal of Jilin University(Medicine Edition), 2025, 51(6): 1709-1716.
| [1] | LHEUREUX S, GOURLEY C, VERGOTE I, et al. Epithelial ovarian cancer[J]. Lancet, 2019, 393(10177): 1240-1253. |
| [2] | SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA A Cancer J Clin, 2024, 74(1): 12-49. |
| [3] | GAITSKELL K, ROGOZIŃSKA E, PLATT S, et al. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer[J]. Cochrane Database Syst Rev, 2023, 4(4): CD007930. |
| [4] | LHEUREUX S, BRAUNSTEIN M, OZA A M. Epithelial ovarian cancer: Evolution of management in the era of precision medicine[J]. CA Cancer J Clin, 2019, 69(4): 280-304. |
| [5] | BU Y H, WU H, DENG R, et al. Therapeutic potential of SphK1 inhibitors based on abnormal expression of SphK1 in inflammatory immune related-diseases[J]. Front Pharmacol, 2021, 12: 733387. |
| [6] | KHOEI S G, SADEGHI H, SAMADI P, et al. Relationship between Sphk1/S1P and microRNAs in human cancers[J]. Biotechnol Appl Biochem, 2021, 68(2): 279-287. |
| [7] | HII L W, CHUNG F F, MAI C W, et al. Sphingosine kinase 1 regulates the survival of breast cancer stem cells and non-stem breast cancer cells by suppression of STAT1[J]. Cells, 2020, 9(4): 886. |
| [8] | NAGAHASHI M, MIYOSHI Y. Targeting sphingosine-1-phosphate signaling in breast cancer[J]. Int J Mol Sci, 2024, 25(6): 3354. |
| [9] | BAO J M, ZHI X, YUAN H Y, et al. Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma[J]. Transl Cancer Res, 2023, 12(3): 572-584. |
| [10] | RIBONI L, ABDEL HADI L, NAVONE S E, et al. Sphingosine-1-phosphate in the tumor microenvironment: a signaling hub regulating cancer hallmarks[J]. Cells, 2020, 9(2): 337. |
| [11] | BEACH J A, ASPURIA P P, CHEON D J, et al. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer[J]. Oncotarget, 2016, 7(4): 4167-4182. |
| [12] | HART P C, CHIYODA T, LIU X J, et al. SPHK1 is a novel target of metformin in ovarian cancer[J]. Mol Cancer Res, 2019, 17(4): 870-881. |
| [13] | ZHANG H W, WANG Q Y, ZHAO Q, et al. miR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1[J]. J Ovarian Res, 2013, 6(1): 84. |
| [14] | DAI L, LIU Y X, XIE L, et al. Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis[J]. Oncotarget, 2017, 8(43): 74947-74961. |
| [15] | RAMOS A, SADEGHI S, TABATABAEIAN H. Battling chemoresistance in cancer: root causes and strategies to uproot them[J]. Int J Mol Sci, 2021, 22(17): 9451. |
| [16] | ALKAFAAS S S, ELSALAHATY M I, ISMAIL D F, et al. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target[J]. Cancer Cell Int, 2024, 24(1): 89. |
| [17] | LING Q, JI K, CHEN J, et al. Sphingosine kinase-1 regulates migration and invasion of gastric cancer cells via targeting the nuclear factor-κB signaling pathway[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2024, 44(11): 2163-2171. |
| [18] | MA Y F, XING X, KONG R R, et al. SphK1 promotes development of non-small cell lung cancer through activation of STAT3[J]. Int J Mol Med, 2020, 47(1): 374-386. |
| [19] | WANG S S, LIANG Y Y, CHANG W X, et al. Triple negative breast cancer depends on sphingosine kinase 1 (SphK1)/sphingosine-1-phosphate (S1P)/sphingosine 1-phosphate receptor 3 (S1PR3)/Notch signaling for metastasis[J]. Med Sci Monit, 2018, 24: 1912-1923. |
| [20] | LIU D, LIU L L, LI H M, et al. Sphingosine kinase 1 counteracts chemosensitivity and immune evasion in diffuse large B cell lymphoma cells via the PI3K/AKT/PD-L1 axis[J]. Int Immunopharmacol, 2024, 143(Pt 2): 113361. |
| [21] | FANG Q, CHEN X, CAO F, et al. SPHK1 promotes HNSCC immune evasion by regulating the MMP1-PD-L1 axis[J]. Theranostics, 2024, 14(18): 7199-7218. |
| [22] |
QIN Z J, TONG H, LI T H, et al. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis[J]. Int J Mol Med, 2021, 48(5). DOI:10.3892/ijmm.2021.5037 .
doi: 10.3892/ijmm.2021.5037 |
| [23] | KAO W H, LIAO L Z, CHEN Y, et al. SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade[J]. Cell Death Dis, 2024, 15(9): 678. |
| [24] | QIU J G, XU Q, PANAH T, et al. Reactive oxygen species mediate ovarian cancer development, platinum resistance, and angiogenesis via CXCL8 and GSK-3β/p70S6K1 axis[J]. Genes Dis, 2025, 12(2): 101378. |
| [25] | ZHU J W, CHARKHCHI P, AKBARI M R. Potential clinical utility of liquid biopsies in ovarian cancer[J]. Mol Cancer, 2022, 21(1): 114. |
| [26] | WANG C, LI Q, SONG K Q, et al. Nanoparticle co-delivery of carboplatin and PF543 restores platinum sensitivity in ovarian cancer models through inhibiting platinum-induced pro-survival pathway activation[J]. Nanoscale Adv, 2024, 6(16): 4082-4093. |
| [1] | Yutian ZHANG,Hailing WU,Keqi LIAO,Shuling LIANG,Shengnan LI,You LI. Construction of TAGLN2 shRNA lentiviral vector and establishment of its stably transfected cell line [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 536-542. |
| [2] | Zhaochun WU,You LI,Jiawen HE,Keqi LIAO,Shengnan LI. Construction of PRDM5 over-expression lentivirus vector and establishment of stably transfected Neuro-2a cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 1-8. |
| [3] | Shengnan LI,Jiawen HE,Keqi LIAO,You LI. Construction of dedicator of cytokinesis 4 over-expressed lentivirus vector and establishment of stable transfected Neuro-2a cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1322-1329. |
| [4] | Jiawen HE,You LI,Keqi LIAO,Shengnan LI. Construction of EIF4A3 shRNA lentiviral vector and establishment of its stable transfection cell line [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 831-839. |
| [5] | Yeteng MU,Chong GUO,Nannan HU,Fuxu YANG,Han XUE,Yuxin FAN,Fenglin GUO,Xingang GUAN. Construction of immune checkpoint TIGIT lentivirus expression vector and establishment of cell line stably expressing TIGIT [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1341-1347. |
| [6] | Jingjing GE,Hongxia XU,Lixia XIE,Kaili DU,Ming SANG,Xiaodong SUN. Establishment of human serous ovarian cancer cell culture system in vitro and its application in chemotherapeutic drug sensitivity detection [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 999-1007. |
| [7] | Pei GONG, Jingran LIU, Shimin ZHAO, Yuzhen WANG, Jiming XIE. Inhibitory effect of MCM10 silencing on proliferation of breast cancer MDA-MB-231 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 652-659. |
| [8] | Chongjun XU,Hefan HE,Qun LIN,Tao ZHANG. Construction of human hepatocyte growth factor gene lentivirus vector and its expression in bone marrow mesenchymal stem cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 16-24. |
| [9] | CHEN Shaofeng, LI Shengnan, DENG Fu, ZHU Peiyi, LI You. Construction of RHBDF2 gene over-expression lentivirus vector and establishment of RHBDF2 cell line stably expressing RHBDF2 [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 444-450. |
| [10] | LI Songyan, LIN Dongjing, YU Yang, LIU Shibing, XU Lu, SUN Qi, XU Ye. Effect of silencing sirtuin 3 on resveratrol-induced apoptosis of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 45-49. |
| [11] | LI Shengnan, CHEN Wuhai, CHEN Shaofeng, DENG Fu, ZHU Peiyi, LI You. Construction of RHBDF2-shRNA lentiviral vector and establishment of stably transfected Neuro-2a-RHBDF2-shRNAcell line [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1224-1230. |
| [12] | LI Shengnan, WANG Mengxu, HU Weidong, CHEN Shaofeng, CHEN Xinglan, LI You. Construction and identification of miR-186 overexpression lentiviral vector [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 997-1002. |
| [13] | LIANG Chunmei, XU Xusan, YU Huajun, ZHOU Xia, WEN Xia, LI You, KOJIC Snezana, WANG Yajun, MA Guoda. Construction and identification of recombinant lentivirus overexpression and RNA interference vector containing cardiac adriamycin reactive protein gene [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 766-771. |
| [14] | WANG Yipin, HE Dongyun, HUANG Qiongwei, SHENG Minjia. Application value of risk ovarian malignancy algorithm in early diagnosis of epithelial ovarian cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 905-910. |
| [15] | PEI Yanling, LYU Hanghang, WANG Bowei, ZHANG Weiyang. Misdiagnosis of ovarian fibrothecoma as ovarian malignant tumor: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 940-943. |